Acrinova AB Series B (ACRI-B) - Total Liabilities

Latest as of March 2026: Skr453.97 Million SEK ≈ $48.85 Million USD

Based on the latest financial reports, Acrinova AB Series B (ACRI-B) has total liabilities worth Skr453.97 Million SEK (≈ $48.85 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Acrinova AB Series B - Total Liabilities Trend (2014–2025)

This chart illustrates how Acrinova AB Series B's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Acrinova AB Series B to evaluate short-term liquidity relative to the company's equity base.

Acrinova AB Series B Competitors by Total Liabilities

The table below lists competitors of Acrinova AB Series B ranked by their total liabilities.

Company Country Total Liabilities
BoomBit S.A
WAR:BBT
Poland zł50.80 Million
HG Capital Trust PLC
LSE:HGT
UK GBX38.12 Million
Patentus SA
WAR:PAT
Poland zł27.07 Million
CLPS INC. DL-0001
F:1UK
Germany €56.23 Million
Lincoln Minerals Ltd
AU:LML
Australia AU$558.38K
Reitmans Canada Ltd
V:RET
Canada CA$266.94 Million
Maternus-Kliniken Aktiengesellschaft
F:MAK
Germany €206.72 Million
AYS Ventures Bhd
KLSE:5021
Malaysia RM622.89 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Acrinova AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Acrinova AB Series B market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.96 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.81 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.45 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Acrinova AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Acrinova AB Series B (2014–2025)

The table below shows the annual total liabilities of Acrinova AB Series B from 2014 to 2025.

Year Total Liabilities Change
2025-12-31 Skr471.06 Million
≈ $50.69 Million
-61.59%
2024-12-31 Skr1.23 Billion
≈ $131.96 Million
+0.81%
2023-12-31 Skr1.22 Billion
≈ $130.90 Million
+5.37%
2022-12-31 Skr1.15 Billion
≈ $124.23 Million
+20.72%
2021-12-31 Skr956.25 Million
≈ $102.91 Million
+77.66%
2020-12-31 Skr538.24 Million
≈ $57.92 Million
+30.33%
2019-12-31 Skr412.98 Million
≈ $44.44 Million
+51.60%
2018-12-31 Skr272.41 Million
≈ $29.32 Million
+16.20%
2017-12-31 Skr234.44 Million
≈ $25.23 Million
+16.71%
2016-12-31 Skr200.88 Million
≈ $21.62 Million
+1448.74%
2015-12-31 Skr12.97 Million
≈ $1.40 Million
-84.72%
2014-12-31 Skr84.86 Million
≈ $9.13 Million
--

About Acrinova AB Series B

ST:ACRI-B Sweden Real Estate - Diversified
Market Cap
$22.08 Million
Skr205.19 Million SEK
Market Cap Rank
#24819 Global
#497 in Sweden
Share Price
Skr7.20
Change (1 day)
+0.00%
52-Week Range
Skr7.20 - Skr14.50
All Time High
Skr14.50
About

Acrinova AB (publ), a real estate company, owns, develops, and manages real estate properties in Sweden. It offers residential properties, offices, and logistics/production properties. The company was incorporated in 2014 and is headquartered in Malmö, Sweden.